Stage Cell Therapeutics Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 23
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Stage Cell Therapeutics General Information

Description

Biotechnology company engaged in cell-based therapies. The company is the developer of a technology platform enabling rapid development and production of cell therapeutics. The company also is engaged in clinical study of a therapy to treat CMV (cytomegalovirus) infections, in particular those arising after stem-cell transplants for hematologic cancers.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Rudolf-Wissell-Street 28
  • 37079 Göttingen
  • Germany
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Stage Cell Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Stage Cell Therapeutics‘s full profile, request access.

Request a free trial

Stage Cell Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Stefan Dreher Scientist, Research & Development
You’re viewing 1 of 3 executive team members. Get the full list »

Stage Cell Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial